Correlation Between Verrica Pharmaceuticals and MiMedx
Can any of the company-specific risk be diversified away by investing in both Verrica Pharmaceuticals and MiMedx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verrica Pharmaceuticals and MiMedx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verrica Pharmaceuticals and MiMedx Group, you can compare the effects of market volatilities on Verrica Pharmaceuticals and MiMedx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verrica Pharmaceuticals with a short position of MiMedx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verrica Pharmaceuticals and MiMedx.
Diversification Opportunities for Verrica Pharmaceuticals and MiMedx
-0.66 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Verrica and MiMedx is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and MiMedx Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MiMedx Group and Verrica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verrica Pharmaceuticals are associated (or correlated) with MiMedx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MiMedx Group has no effect on the direction of Verrica Pharmaceuticals i.e., Verrica Pharmaceuticals and MiMedx go up and down completely randomly.
Pair Corralation between Verrica Pharmaceuticals and MiMedx
Given the investment horizon of 90 days Verrica Pharmaceuticals is expected to generate 2.22 times more return on investment than MiMedx. However, Verrica Pharmaceuticals is 2.22 times more volatile than MiMedx Group. It trades about -0.01 of its potential returns per unit of risk. MiMedx Group is currently generating about -0.19 per unit of risk. If you would invest 70.00 in Verrica Pharmaceuticals on November 1, 2024 and sell it today you would lose (1.54) from holding Verrica Pharmaceuticals or give up 2.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Verrica Pharmaceuticals vs. MiMedx Group
Performance |
| Timeline |
| Verrica Pharmaceuticals |
| MiMedx Group |
Verrica Pharmaceuticals and MiMedx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verrica Pharmaceuticals and MiMedx
The main advantage of trading using opposite Verrica Pharmaceuticals and MiMedx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verrica Pharmaceuticals position performs unexpectedly, MiMedx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MiMedx will offset losses from the drop in MiMedx's long position.| Verrica Pharmaceuticals vs. Inventiva Sa | Verrica Pharmaceuticals vs. Edgewise Therapeutics | Verrica Pharmaceuticals vs. Vigil Neuroscience | Verrica Pharmaceuticals vs. Connect Biopharma Holdings |
| MiMedx vs. Monte Rosa Therapeutics | MiMedx vs. Design Therapeutics | MiMedx vs. Werewolf Therapeutics | MiMedx vs. Ikena Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |